• Product NameLornoxicam
• Brief DescriptionInhibitors
• Purification99.53%
• Biological ActivityLornoxicam (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. Lornoxicam differs from other oxicam compounds in its potent inhibition of prostaglandin biosynthesis, a property that explains the particularly pronounced efficacy of the drug. Lornoxicam is approved for use in Japan.
• Target NameCOX inhibitor
• CAS No. 70374-39-9
• Calculated MW 371.82
• Formulation C13H10ClN3O4S2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O
  Pathways:Immunology/Inflammation; Neuroscience
  Receptor:COX-1; COX-2
  Boling pt:
  Melting pt:225-230C
  Solubility:DMSO: 2 mg/mL (5.37 mM)
  Appearance:Yellow Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Renner RM, et al. Contraception. 2010 May;81(5):372-88.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting